Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.

Source:http://linkedlifedata.com/resource/pubmed/id/19148529

Download in:

View as

General Info

PMID
19148529